NASDAQ: ASMB       Assembly Biosciences
Last Price Today's Change   Day's Range   Trading Volume
1.66   -0.05 (2.92%)  1.65 - 1.71  33,140


Avg Volume (4 weeks):332,246
4 Weeks Range:1.32 - 2.145
4 Weeks Price Volatility (%):
52 Weeks Range:1.32 - 4.69
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Assembly Biosciences Inc is a clinical stage biotechnology company. It is advancing two innovative platform programs, a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company’s HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2025  2270  297  7699 

Top 10 Active Counters
 ISBC 13.87-0.35 
 NU 3.885-0.195 
 AMD 102.77+0.30 
 NIO 16.861+0.231 
 AMC 13.888+0.988 
 TGT 163.89-51.39 
 AAPL 145.34-3.90 
 DISCA 24.43+1.36 
 SOFI 7.436+0.386 
 F 13.115-0.415